The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study.
 
Mehmet Artac
Honoraria - Amgen; Bayer; Merck; Pfizer; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche
 
Mahmut Emre Yildirim
No Relationships to Disclose
 
Ahmet Taner Sümbül
No Relationships to Disclose
 
Akin Ozturk
No Relationships to Disclose
 
Nuri Karadurmus
No Relationships to Disclose
 
Lokman Koral
No Relationships to Disclose
 
Umut Demirci
Honoraria - Abdi Ibrahim; AstraZeneca; AstraZeneca; BMS Turkey; CTGEN; Daiichi Sankyo/Astra Zeneca; Gen; Gilead Sciences; GlaxoSmithKline; Lilly; Menarini; Merck Serono; MSD; Novartis; Roche; Sandoz
Consulting or Advisory Role - Gilead Sciences; Menarini; MSD; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Gen; Pfizer
 
Cagatay Arslan
Consulting or Advisory Role - Novartis, Merck, Astra Zeneca, Johnson &Johnson, Teva, Astellas, BMS, Amgen, Bayer
Speakers' Bureau - Novartis, Merck, Astra Zeneca, Johnson &Johnson, Teva, Astellas, BMS, Amgen, Bayer
Research Funding - Roche, Novartis, BMS, Merck, MSD, Astra Zeneca, Nektar, Johnson &Johnson, Lilly, Amgen, Incyte, Bayer, Yuhan, Henlius, Pfizer, Biontech, Genmab, Beigene, GSK
 
Mahmut Gumus
Honoraria - GlaxoSmithKline (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst)
Consulting or Advisory Role - Amgen (Inst); Gen (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Roche; Takeda (Inst)
Speakers' Bureau - Amgen (Inst); MSD Oncology (Inst); Novartis (Inst); Polipharma (Inst); Roche (Inst)
Research Funding - Amgen (Inst); MSD Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Umut Kefeli
No Relationships to Disclose
 
Ozlem Ercelep
No Relationships to Disclose
 
Sinemis Celik
No Relationships to Disclose
 
Oktay Bozkurt
No Relationships to Disclose
 
Bala Basak Oven
No Relationships to Disclose
 
Erdem Cubukcu
No Relationships to Disclose
 
Mustafa Karaca
No Relationships to Disclose
 
Ahmet Bilici
No Relationships to Disclose
 
Deniz Tural
No Relationships to Disclose
 
Hakan Harputluoglu
No Relationships to Disclose
 
Faysal Dane
No Relationships to Disclose